Overview
Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis
Status:
Unknown status
Unknown status
Trial end date:
2017-12-01
2017-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine whether the novel aspiration thrombectomy device combined with catheter-directed thrombolysis is effective in the treatment of acute iliofemoral deep venous thrombosis (IF-DVT).Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Xuzhou Medical UniversityTreatments:
Calcium
Calcium heparin
Calcium, Dietary
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
Tinzaparin
Criteria
Inclusion Criteria:- Clinical diagnosis of iliofemoral deep venous thrombosis
- Symptoms of less than 14 days' duration
- With good function status
- A life expectancy of more than 1 year
- A low risk of bleeding
Exclusion Criteria:
- Without iliac vein thrombosis
- Anticoagulation and/or thrombolysis contraindications
- Systemic infection
- Heart, hepatic, renal function insufficiency